 | • レポートコード：QYR2104Z4105 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、神経梅毒のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（無症候性神経梅毒、髄膜神経梅毒、髄膜血管神経梅毒、その他）、用途別市場規模（病院＆診療所、医学研究センター、学術研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・神経梅毒の市場動向 ・企業の競争状況、市場シェア ・神経梅毒の種類別市場規模（無症候性神経梅毒、髄膜神経梅毒、髄膜血管神経梅毒、その他） ・神経梅毒の用途別市場規模（病院＆診療所、医学研究センター、学術研究機関） ・神経梅毒の北米市場規模2016-2027（アメリカ、カナダ） ・神経梅毒のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経梅毒のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経梅毒の中南米市場規模2016-2027（メキシコ、ブラジル） ・神経梅毒の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Bayer、Eli Lilly and Company、GlaxoSmithKline、Novartis、Pfizer、Sanofi） ・結論 |
Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%–40% of those who are not treated. The United States’ Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.
Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer’s disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.
Market Analysis and Insights: Global Neurosyphilis Market
The global Neurosyphilis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neurosyphilis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neurosyphilis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neurosyphilis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neurosyphilis market.
Global Neurosyphilis Scope and Market Size
Neurosyphilis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurosyphilis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
Others
Segment by Application
Hospital & Clinics
Medical Research Centers
Academic Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurosyphilis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Asymptomatic Neurosyphilis
1.2.3 Meningeal Neurosyphilis
1.2.4 Meningovascular Neurosyphilis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neurosyphilis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Medical Research Centers
1.3.4 Academic Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neurosyphilis Market Perspective (2016-2027)
2.2 Neurosyphilis Growth Trends by Regions
2.2.1 Neurosyphilis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neurosyphilis Historic Market Share by Regions (2016-2021)
2.2.3 Neurosyphilis Forecasted Market Size by Regions (2022-2027)
2.3 Neurosyphilis Industry Dynamic
2.3.1 Neurosyphilis Market Trends
2.3.2 Neurosyphilis Market Drivers
2.3.3 Neurosyphilis Market Challenges
2.3.4 Neurosyphilis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurosyphilis Players by Revenue
3.1.1 Global Top Neurosyphilis Players by Revenue (2016-2021)
3.1.2 Global Neurosyphilis Revenue Market Share by Players (2016-2021)
3.2 Global Neurosyphilis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neurosyphilis Revenue
3.4 Global Neurosyphilis Market Concentration Ratio
3.4.1 Global Neurosyphilis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurosyphilis Revenue in 2020
3.5 Neurosyphilis Key Players Head office and Area Served
3.6 Key Players Neurosyphilis Product Solution and Service
3.7 Date of Enter into Neurosyphilis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurosyphilis Breakdown Data by Type
4.1 Global Neurosyphilis Historic Market Size by Type (2016-2021)
4.2 Global Neurosyphilis Forecasted Market Size by Type (2022-2027)
5 Neurosyphilis Breakdown Data by Application
5.1 Global Neurosyphilis Historic Market Size by Application (2016-2021)
5.2 Global Neurosyphilis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Neurosyphilis Market Size (2016-2027)
6.2 North America Neurosyphilis Market Size by Type
6.2.1 North America Neurosyphilis Market Size by Type (2016-2021)
6.2.2 North America Neurosyphilis Market Size by Type (2022-2027)
6.2.3 North America Neurosyphilis Market Size by Type (2016-2027)
6.3 North America Neurosyphilis Market Size by Application
6.3.1 North America Neurosyphilis Market Size by Application (2016-2021)
6.3.2 North America Neurosyphilis Market Size by Application (2022-2027)
6.3.3 North America Neurosyphilis Market Size by Application (2016-2027)
6.4 North America Neurosyphilis Market Size by Country
6.4.1 North America Neurosyphilis Market Size by Country (2016-2021)
6.4.2 North America Neurosyphilis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Neurosyphilis Market Size (2016-2027)
7.2 Europe Neurosyphilis Market Size by Type
7.2.1 Europe Neurosyphilis Market Size by Type (2016-2021)
7.2.2 Europe Neurosyphilis Market Size by Type (2022-2027)
7.2.3 Europe Neurosyphilis Market Size by Type (2016-2027)
7.3 Europe Neurosyphilis Market Size by Application
7.3.1 Europe Neurosyphilis Market Size by Application (2016-2021)
7.3.2 Europe Neurosyphilis Market Size by Application (2022-2027)
7.3.3 Europe Neurosyphilis Market Size by Application (2016-2027)
7.4 Europe Neurosyphilis Market Size by Country
7.4.1 Europe Neurosyphilis Market Size by Country (2016-2021)
7.4.2 Europe Neurosyphilis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Neurosyphilis Market Size (2016-2027)
8.2 Asia-Pacific Neurosyphilis Market Size by Type
8.2.1 Asia-Pacific Neurosyphilis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neurosyphilis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neurosyphilis Market Size by Type (2016-2027)
8.3 Asia-Pacific Neurosyphilis Market Size by Application
8.3.1 Asia-Pacific Neurosyphilis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neurosyphilis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neurosyphilis Market Size by Application (2016-2027)
8.4 Asia-Pacific Neurosyphilis Market Size by Region
8.4.1 Asia-Pacific Neurosyphilis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neurosyphilis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neurosyphilis Market Size (2016-2027)
9.2 Latin America Neurosyphilis Market Size by Type
9.2.1 Latin America Neurosyphilis Market Size by Type (2016-2021)
9.2.2 Latin America Neurosyphilis Market Size by Type (2022-2027)
9.2.3 Latin America Neurosyphilis Market Size by Type (2016-2027)
9.3 Latin America Neurosyphilis Market Size by Application
9.3.1 Latin America Neurosyphilis Market Size by Application (2016-2021)
9.3.2 Latin America Neurosyphilis Market Size by Application (2022-2027)
9.3.3 Latin America Neurosyphilis Market Size by Application (2016-2027)
9.4 Latin America Neurosyphilis Market Size by Country
9.4.1 Latin America Neurosyphilis Market Size by Country (2016-2021)
9.4.2 Latin America Neurosyphilis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurosyphilis Market Size (2016-2027)
10.2 Middle East & Africa Neurosyphilis Market Size by Type
10.2.1 Middle East & Africa Neurosyphilis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neurosyphilis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neurosyphilis Market Size by Type (2016-2027)
10.3 Middle East & Africa Neurosyphilis Market Size by Application
10.3.1 Middle East & Africa Neurosyphilis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neurosyphilis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neurosyphilis Market Size by Application (2016-2027)
10.4 Middle East & Africa Neurosyphilis Market Size by Country
10.4.1 Middle East & Africa Neurosyphilis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neurosyphilis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Neurosyphilis Introduction
11.1.4 Abbott Revenue in Neurosyphilis Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Neurosyphilis Introduction
11.2.4 Bayer Revenue in Neurosyphilis Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Neurosyphilis Introduction
11.3.4 Eli Lilly and Company Revenue in Neurosyphilis Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Neurosyphilis Introduction
11.4.4 GlaxoSmithKline Revenue in Neurosyphilis Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Neurosyphilis Introduction
11.5.4 Novartis Revenue in Neurosyphilis Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Neurosyphilis Introduction
11.6.4 Pfizer Revenue in Neurosyphilis Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Neurosyphilis Introduction
11.7.4 Sanofi Revenue in Neurosyphilis Business (2016-2021)
11.7.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Neurosyphilis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Asymptomatic Neurosyphilis
Table 3. Key Players of Meningeal Neurosyphilis
Table 4. Key Players of Meningovascular Neurosyphilis
Table 5. Key Players of Others
Table 6. Global Neurosyphilis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Neurosyphilis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Neurosyphilis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Neurosyphilis Market Share by Regions (2016-2021)
Table 10. Global Neurosyphilis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Neurosyphilis Market Share by Regions (2022-2027)
Table 12. Neurosyphilis Market Trends
Table 13. Neurosyphilis Market Drivers
Table 14. Neurosyphilis Market Challenges
Table 15. Neurosyphilis Market Restraints
Table 16. Global Neurosyphilis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Neurosyphilis Market Share by Players (2016-2021)
Table 18. Global Top Neurosyphilis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurosyphilis as of 2020)
Table 19. Ranking of Global Top Neurosyphilis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Neurosyphilis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Neurosyphilis Product Solution and Service
Table 23. Date of Enter into Neurosyphilis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neurosyphilis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Neurosyphilis Revenue Market Share by Type (2016-2021)
Table 27. Global Neurosyphilis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Neurosyphilis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Neurosyphilis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Neurosyphilis Revenue Market Share by Application (2016-2021)
Table 31. Global Neurosyphilis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Neurosyphilis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Neurosyphilis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Neurosyphilis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Neurosyphilis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Neurosyphilis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Neurosyphilis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Neurosyphilis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Neurosyphilis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Neurosyphilis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Neurosyphilis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Neurosyphilis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Neurosyphilis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Neurosyphilis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Neurosyphilis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Neurosyphilis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neurosyphilis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Neurosyphilis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Neurosyphilis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Neurosyphilis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Neurosyphilis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Neurosyphilis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Neurosyphilis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Neurosyphilis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Neurosyphilis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Neurosyphilis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Neurosyphilis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Neurosyphilis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neurosyphilis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Neurosyphilis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Neurosyphilis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Neurosyphilis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Neurosyphilis Product
Table 66. Abbott Revenue in Neurosyphilis Business (2016-2021) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Bayer Company Details
Table 69. Bayer Business Overview
Table 70. Bayer Neurosyphilis Product
Table 71. Bayer Revenue in Neurosyphilis Business (2016-2021) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. Eli Lilly and Company Company Details
Table 74. Eli Lilly and Company Business Overview
Table 75. Eli Lilly and Company Neurosyphilis Product
Table 76. Eli Lilly and Company Revenue in Neurosyphilis Business (2016-2021) & (US$ Million)
Table 77. Eli Lilly and Company Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Neurosyphilis Product
Table 81. GlaxoSmithKline Revenue in Neurosyphilis Business (2016-2021) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Neurosyphilis Product
Table 86. Novartis Revenue in Neurosyphilis Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Neurosyphilis Product
Table 91. Pfizer Revenue in Neurosyphilis Business (2016-2021) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Neurosyphilis Product
Table 96. Sanofi Revenue in Neurosyphilis Business (2016-2021) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurosyphilis Market Share by Type: 2020 VS 2027
Figure 2. Asymptomatic Neurosyphilis Features
Figure 3. Meningeal Neurosyphilis Features
Figure 4. Meningovascular Neurosyphilis Features
Figure 5. Others Features
Figure 6. Global Neurosyphilis Market Share by Application: 2020 VS 2027
Figure 7. Hospital & Clinics Case Studies
Figure 8. Medical Research Centers Case Studies
Figure 9. Academic Institutes Case Studies
Figure 10. Neurosyphilis Report Years Considered
Figure 11. Global Neurosyphilis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Neurosyphilis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Neurosyphilis Market Share by Regions: 2020 VS 2027
Figure 14. Global Neurosyphilis Market Share by Regions (2022-2027)
Figure 15. Global Neurosyphilis Market Share by Players in 2020
Figure 16. Global Top Neurosyphilis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurosyphilis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Neurosyphilis Revenue in 2020
Figure 18. Global Neurosyphilis Revenue Market Share by Type (2016-2021)
Figure 19. Global Neurosyphilis Revenue Market Share by Type (2022-2027)
Figure 20. North America Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Neurosyphilis Market Share by Type (2016-2027)
Figure 22. North America Neurosyphilis Market Share by Application (2016-2027)
Figure 23. North America Neurosyphilis Market Share by Country (2016-2027)
Figure 24. United States Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Neurosyphilis Market Share by Type (2016-2027)
Figure 28. Europe Neurosyphilis Market Share by Application (2016-2027)
Figure 29. Europe Neurosyphilis Market Share by Country (2016-2027)
Figure 30. Germany Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Neurosyphilis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Neurosyphilis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Neurosyphilis Market Share by Region (2016-2027)
Figure 40. China Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Neurosyphilis Market Share by Type (2016-2027)
Figure 48. Latin America Neurosyphilis Market Share by Application (2016-2027)
Figure 49. Latin America Neurosyphilis Market Share by Country (2016-2027)
Figure 50. Mexico Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Neurosyphilis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Neurosyphilis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Neurosyphilis Market Share by Country (2016-2027)
Figure 56. Turkey Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Neurosyphilis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Neurosyphilis Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Neurosyphilis Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Neurosyphilis Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Neurosyphilis Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Neurosyphilis Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Neurosyphilis Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Neurosyphilis Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の脳卒中センター市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Stroke Centers Market The global Stroke Centers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…- 世界のストア医療における小売クリニック市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Retail Clinics In Store Healthcare Market The global Retail Clinics In Store Healthcare market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high …
- 世界の外来クリニック市場規模・現状・予測（2021年-2027年） The outpatient clinics has continued to play a significant role in management of the cognitive behavioral disorders. High-risk situations such as substance abuse, sexual offence, depression, obesity and obsessive-compulsive behavior is becoming a major concern in various countries. Management of hig…
- 世界のカルシフィラキシス治療市場規模・現状・予測（2021年-2027年） Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare condition characterized by calcification or the aggregation of calcium in a patient’s blood vessels and the development of thrombosis. This can lead to the death of cells in a patient’s skin and fatty tissues, thereby causi…
- 世界の動物病院・獣医クリニックサービス市場規模・現状・予測（2021年-2027年） Veterinary Clinic are those premises at which veterinary surgery is practiced, but at which animals are not retained overnight. In veterinary hospitals veterinary surgery is practiced and animals receive treatment, nursing care, and other services. Services in veterinary hospitals include reception,…